tm logo

Monitor this mark

View On USPTO

ARNUITY ELLIPTA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 30 Oct 2021

Last Applicant/ Owned by

Glaxo Group Limited

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

86230290 filed on 24th Mar 2014

Registration Number

4823045 registered on 29th Sep 2015

in the Principal Register

Correspondent Address

Christopher M. Hanes

Christopher M. Hanes GSK

Legal Brand Protection

Durham, NC 27701

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ARNUITY ELLIPTA

Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders

First Use Date in General

05th Jan 2015

First Use Date in Commerce

05th Jan 2015

Mark Details

Serial Number

No 86230290

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 81240347

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Oct 2024TEAS SECTION 8 & 9 RECEIVED
29th Sep 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27th Jun 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
27th Jun 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Jun 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27th Jun 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27th Jun 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
28th Oct 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
28th Oct 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28th Oct 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED